RU2005141382A - METHOD FOR TREATING NEUROTROPHIC DISTURBANCES DUE TO SPINAL CORD INJURIES - Google Patents

METHOD FOR TREATING NEUROTROPHIC DISTURBANCES DUE TO SPINAL CORD INJURIES Download PDF

Info

Publication number
RU2005141382A
RU2005141382A RU2005141382/14A RU2005141382A RU2005141382A RU 2005141382 A RU2005141382 A RU 2005141382A RU 2005141382/14 A RU2005141382/14 A RU 2005141382/14A RU 2005141382 A RU2005141382 A RU 2005141382A RU 2005141382 A RU2005141382 A RU 2005141382A
Authority
RU
Russia
Prior art keywords
spinal cord
cord injuries
disturbances due
treating
neurotrophic
Prior art date
Application number
RU2005141382/14A
Other languages
Russian (ru)
Other versions
RU2307679C1 (en
Inventor
Резеда Ахметовна Бодрова (RU)
Резеда Ахметовна Бодрова
ков Виктор Николаевич Падир (RU)
Виктор Николаевич Падиряков
Марина Анатольевна Васильева (RU)
Марина Анатольевна Васильева
Original Assignee
Казанска государственна медицинска академи (RU)
Казанская государственная медицинская академия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Казанска государственна медицинска академи (RU), Казанская государственная медицинская академия filed Critical Казанска государственна медицинска академи (RU)
Priority to RU2005141382/14A priority Critical patent/RU2307679C1/en
Publication of RU2005141382A publication Critical patent/RU2005141382A/en
Application granted granted Critical
Publication of RU2307679C1 publication Critical patent/RU2307679C1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ лечения нейротрофических нарушений при последствиях травм спинного мозга, отличающийся тем, что применяется местно аэроионофорез вобэнзима в виде порошка в дозе 250 мг в количестве 15 процедур.A method of treating neurotrophic disorders in the aftermath of spinal cord injuries, characterized in that topically applied Wobenzyme aeroionophoresis in the form of a powder in a dose of 250 mg in an amount of 15 procedures is used.
RU2005141382/14A 2005-12-13 2005-12-13 Method for treating neurotrophic disorders cases caused by spinal cord injuries complications RU2307679C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005141382/14A RU2307679C1 (en) 2005-12-13 2005-12-13 Method for treating neurotrophic disorders cases caused by spinal cord injuries complications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005141382/14A RU2307679C1 (en) 2005-12-13 2005-12-13 Method for treating neurotrophic disorders cases caused by spinal cord injuries complications

Publications (2)

Publication Number Publication Date
RU2005141382A true RU2005141382A (en) 2007-07-10
RU2307679C1 RU2307679C1 (en) 2007-10-10

Family

ID=38316399

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005141382/14A RU2307679C1 (en) 2005-12-13 2005-12-13 Method for treating neurotrophic disorders cases caused by spinal cord injuries complications

Country Status (1)

Country Link
RU (1) RU2307679C1 (en)

Also Published As

Publication number Publication date
RU2307679C1 (en) 2007-10-10

Similar Documents

Publication Publication Date Title
LTC2444424I2 (en) Improved TM nanoparticles for the treatment of aggregation disorders
MX2010006033A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof.
WO2010003127A3 (en) Antagonists of prostaglandin d2 receptors
IS8418A (en) 1,4-diploid isoquinilone derivatives as RAF kinase inhibitors that are useful in the treatment of proliferative disorders
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
AU2003272285A8 (en) Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
ZA200802542B (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
HK1073996A1 (en) Use of adapalene for the treatment of dermatological disorders
WO2009145989A3 (en) Aminoalkylphenyl antagonists of prostaglandin d2 receptors
IL177717A0 (en) Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
PL381247A1 (en) Heterocyclical condensed derivative, the medical composition containing it as well as its treatment application
PL1761266T3 (en) Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
EP1865967A4 (en) Compounds, compositions and methods for the treatment of viral infections and other medical disorders
WO2010057118A3 (en) Heterocyclic antagonists of prostaglandin d2 receptors
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
WO2009046841A8 (en) Piperidine and piperazine derivatives for treating tumours
EP1838320A4 (en) Cxcr4 antagonists for the treatment of medical disorders
WO2010042652A3 (en) Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
PT2056814E (en) 2,5-dihydroxybenzene compounds for the treatment of psoriasis
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
EP2323649A4 (en) Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20071214